Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 4, 2025

November 4, 2025

Pennant Acquires Senior Living Communities in Idaho and Wisconsin

GlobeNewswire

November 4, 2025

Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation

GlobeNewswire

November 4, 2025

Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications

GlobeNewswire

November 4, 2025

Precipio Announces Q3-2025 Shareholder Update Call

GlobeNewswire

November 4, 2025

DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

GlobeNewswire

November 4, 2025

DBV Technologies participera à la 2e conférence annuelle Guggenheim Healthcare Innovation

GlobeNewswire

November 4, 2025

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire

November 4, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 4, 2025

Anaptys Announces Participation in November Investor Conferences

GlobeNewswire

November 4, 2025

Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 4, 2025

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025

GlobeNewswire

November 4, 2025

Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 4, 2025

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences

GlobeNewswire

November 4, 2025

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 4, 2025

Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025

GlobeNewswire

November 4, 2025

Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study

GlobeNewswire

November 4, 2025

OnKure Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

November 4, 2025

OrthoPediatrics to Participate in Upcoming Conferences

GlobeNewswire

November 4, 2025

Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025

GlobeNewswire

November 4, 2025

InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2025

GlobeNewswire